
About Enuncia.ai
Enuncia.ai is a Healthcare company based in Germany founded in 2022 by Julius Behner. AI-powered speech therapy app for diagnostics and treatment is offered. Enuncia.ai has raised $159.95 thousand across 1 funding round. Its chief executive, as recorded, is Julius Behner. Its focus areas include HealthTech, Disease Self Management, Neurological Disorders and Therapy.
Company details
Enuncia.ai was founded in 2022 in Brandenburg, Germany, within the AI health technology sector. An application is provided for diagnosing and treating speech impediments through real-time analysis of speech patterns via AI algorithms. Progress is tracked over time, with detailed reports generated on exercise completion, performance, and speech improvements to support user monitoring. Operations focus on delivering these tools to users seeking speech enhancement.
- Headquarters Brandenburg, Germany
- Founders Julius Behner
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website enuncia.ai
- Social LinkedIn X
- Total Equity Funding$159.95K (USD)
in 1 rounds
- Latest Funding Round$159.95K (USD), Seed
Apr 2024
Funding Insights of Enuncia.ai
Enuncia.ai has successfully raised a total of $159.95K through 1 strategic funding round. The most recent funding activity was a Seed round of $159.95 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $159,945
- Total Rounds 1
- Last Round Seed β $159,945
- First Round $159,945
(Apr 2024)
All 1 funding rounds of Enuncia.ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $159,945 | Seed | β | β | β |
People of Enuncia.ai
1 people are tracked at Enuncia.ai (1 in leadership).
| Name | Role | Group |
|---|---|---|
Julius Behner | Founder & CEO | Leadership |
Complete people profiles for Enuncia.ai
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enuncia.ai
2 dated milestones of Enuncia.ai across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Enuncia.ai is founded.
- Funding First funding round of $160K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enuncia.ai
Enuncia.ai was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Enuncia.ai is headquartered in Germany. It is registered at Brandenburg, Germany.
Julius Behner is the CEO of Enuncia.ai, as recorded in our data. They have also founded this company.
Enuncia.ai is a funded company, having raised a total of $159.95K across 1 funding round to date. The company's 1st funding round was a Seed of $159.95K, raised on Apr 2024.
Enuncia.ai was founded in 2022 in Brandenburg, Germany, within the AI health technology sector. An application is provided for diagnosing and treating speech impediments through real-time analysis of speech patterns via AI algorithms. Progress is tracked over time, with detailed reports generated on exercise completion, performance, and speech improvements to support user monitoring. Operations focus on delivering these tools to users seeking speech enhancement.